ITRM920809A1 - Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica. - Google Patents

Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.

Info

Publication number
ITRM920809A1
ITRM920809A1 IT000809A ITRM920809A ITRM920809A1 IT RM920809 A1 ITRM920809 A1 IT RM920809A1 IT 000809 A IT000809 A IT 000809A IT RM920809 A ITRM920809 A IT RM920809A IT RM920809 A1 ITRM920809 A1 IT RM920809A1
Authority
IT
Italy
Prior art keywords
interleuchina
wild
mutant
biological activity
activity compared
Prior art date
Application number
IT000809A
Other languages
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Publication of ITRM920809A0 publication Critical patent/ITRM920809A0/it
Priority to ITRM920809A priority Critical patent/IT1263022B/it
Priority to CA002129824A priority patent/CA2129824C/en
Priority to JP6511903A priority patent/JP2515491B2/ja
Priority to ES94900984T priority patent/ES2145819T3/es
Priority to DE69328437T priority patent/DE69328437T2/de
Priority to AT94900984T priority patent/ATE191923T1/de
Priority to PT94900984T priority patent/PT667872E/pt
Priority to EP94900984A priority patent/EP0667872B1/en
Priority to DK94900984T priority patent/DK0667872T3/da
Priority to PCT/IT1993/000114 priority patent/WO1994011402A1/en
Publication of ITRM920809A1 publication Critical patent/ITRM920809A1/it
Priority to US08/437,680 priority patent/US5681723A/en
Application granted granted Critical
Publication of IT1263022B publication Critical patent/IT1263022B/it
Priority to GR20000401372T priority patent/GR3033685T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ITRM920809A 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica. IT1263022B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM920809A IT1263022B (it) 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
PT94900984T PT667872E (pt) 1992-11-06 1993-11-02 Interleucina-6 mutante com actividade biologica melhorada em relacao a da interleucina 6 selvagem
DK94900984T DK0667872T3 (da) 1992-11-06 1993-11-02 Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
ES94900984T ES2145819T3 (es) 1992-11-06 1993-11-02 Interleucina 6 mutante de actividad biologica mejorada con relacion a la de la interleucina 6 salvaje.
DE69328437T DE69328437T2 (de) 1992-11-06 1993-11-02 Interleukine-6 Mutante mit verbesserter biologischer Aktivität im vergleich zu wildtyp IL-6
AT94900984T ATE191923T1 (de) 1992-11-06 1993-11-02 Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6
CA002129824A CA2129824C (en) 1992-11-06 1993-11-02 Mutant interleukin 6 with improved biological activity over wild interleukin 6
EP94900984A EP0667872B1 (en) 1992-11-06 1993-11-02 Mutant interleukin 6 with improved biological activity over wild interleukin 6
JP6511903A JP2515491B2 (ja) 1992-11-06 1993-11-02 野生インタ―ロイキン６より改良された生物学的活性を有する突然変異インタ―ロイキン６
PCT/IT1993/000114 WO1994011402A1 (en) 1992-11-06 1993-11-02 Mutant interleukin 6 with improved biological activity over wild interleukin 6
US08/437,680 US5681723A (en) 1992-11-06 1995-05-05 Mutant interleukin 6 with improved biological activity over wild interleukin 6
GR20000401372T GR3033685T3 (en) 1992-11-06 2000-06-14 Mutant interleukin 6 with improved biological activity over wild interleukin 6.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920809A IT1263022B (it) 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.

Publications (3)

Publication Number Publication Date
ITRM920809A0 ITRM920809A0 (it) 1992-11-06
ITRM920809A1 true ITRM920809A1 (it) 1994-05-06
IT1263022B IT1263022B (it) 1996-07-23

Family

ID=11401276

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920809A IT1263022B (it) 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.

Country Status (12)

Country Link
US (1) US5681723A (it)
EP (1) EP0667872B1 (it)
JP (1) JP2515491B2 (it)
AT (1) ATE191923T1 (it)
CA (1) CA2129824C (it)
DE (1) DE69328437T2 (it)
DK (1) DK0667872T3 (it)
ES (1) ES2145819T3 (it)
GR (1) GR3033685T3 (it)
IT (1) IT1263022B (it)
PT (1) PT667872E (it)
WO (1) WO1994011402A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274782B (it) * 1994-12-14 1997-07-24 Angeletti P Ist Richerche Bio Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
WO1997010338A1 (en) * 1995-09-12 1997-03-20 Chiron Corporation Improved interleukin-6 receptor antagonist
WO2001016166A2 (en) * 1999-08-27 2001-03-08 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polypeptides, comprising il-6 ligand-binding receptor domains, and related nucleic acids, antibodies, compositions, and methods of use
IL161673A0 (en) 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
US9751942B2 (en) 2012-03-29 2017-09-05 Chugai Seiyaku Kabushiki Kaisha Anti-LAMP5 antibody and utilization thereof
CN113698467A (zh) * 2020-05-19 2021-11-26 甘李药业股份有限公司 Il-6变体及其用途
US20240269236A1 (en) 2021-06-04 2024-08-15 Sonnet BioTherapeutics, Inc. Methods of treating age-related frailty with interleukin-6

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
US5210075A (en) * 1990-02-16 1993-05-11 Tanabe Seiyaku Co., Ltd. Interleukin 6 antagonist peptides

Also Published As

Publication number Publication date
JPH07501947A (ja) 1995-03-02
EP0667872A1 (en) 1995-08-23
PT667872E (pt) 2000-08-31
GR3033685T3 (en) 2000-10-31
ES2145819T3 (es) 2000-07-16
DE69328437D1 (de) 2000-05-25
EP0667872B1 (en) 2000-04-19
JP2515491B2 (ja) 1996-07-10
WO1994011402A1 (en) 1994-05-26
DE69328437T2 (de) 2000-11-02
CA2129824C (en) 1997-03-04
DK0667872T3 (da) 2000-09-18
CA2129824A1 (en) 1994-05-26
US5681723A (en) 1997-10-28
ITRM920809A0 (it) 1992-11-06
IT1263022B (it) 1996-07-23
ATE191923T1 (de) 2000-05-15

Similar Documents

Publication Publication Date Title
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
HUP0101136A2 (hu) Fehérjeexpresszió baculovírus-vektort alkalmazó expressziós rendszerben
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
DE69941701D1 (de) Mutanten von flt3-l und ihre verwendungen
DE69638314D1 (de) Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie
DK562685A (da) Transformationssystem
DE69534875D1 (de) Kalziumfreie subtilisin mutanten
NL300046I1 (nl) Eiwit met uraat oxidase activiteit, recombinant gen dat hiervoor codeert, expressievector, micro-organismen en getransformeerde cellen.
FI954220A0 (fi) Yhdistelmä-mersasidiini ja sen valmistusmenetelmä
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
GR3033685T3 (en) Mutant interleukin 6 with improved biological activity over wild interleukin 6.
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
EP0785716A4 (en) CYTOKIN DESCRIBED AS LERK6
ATE209252T1 (de) Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
IL75553A0 (en) Ache like peptide
ATE196165T1 (de) Methoden zur herstellung von protein c
MY104405A (en) Structural gene comprising dna coding for an endotoxin protein having toxic activity against insects.
DK0757994T3 (da) TCF-mutanter
Sakharov et al. Purification and some properties of elastase from hepatopancreas of king crab Paralithodes camtschatica
EP1007647A4 (en) PRODUCTION OF THE INGAP PROTEIN WITH A HIGH EXPRESSION RATE
BG44029A3 (en) Method for preparing of n- dimethyl morphinanic derivatives
Perez-Polo et al. The Physical and Biological Properties of 7S and β-NGF from the Mouse Submaxillary Gland
SE9803398D0 (sv) "New use"
Biedermann et al. Homogeneity analysis of a nuclease secreted by E. coli.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970923